Kjersti Lønning1,2, Karsten Midtvedt1, Tomm Bernklev2,3, Cathrine Brunborg4, Marit H Andersen1,5, Nanna von der Lippe2, Anna V Reisaeter1, Pål-Dag Line1,2, Anders Hartmann1,2, Kristian Heldal2,6. 1. Department of Transplantation Medicine, Oslo University Hospital, Rikshospitalet, Norway. 2. Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 3. Department of Research and Development, Vestfold Hospital Trust, Tønsberg, Norway. 4. Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway. 5. Faculty of Medicine, Department of Health Sciences, University of Oslo, Oslo, Norway. 6. Department of Cardiology, Nephrology, Endocrinology and Emergency Medicine, Clinic of Internal Medicine, Telemark Hospital Trust, Skien, Norway.
Abstract
AIM: There is limited available knowledge regarding health-related quality of life (HRQoL) in older patients with chronic kidney disease. We aimed to describe HRQoL in renal transplant candidates 65 years or older at transplant acceptance, and during the first year on the waiting list. METHODS: A nationwide prospective observational study in Norway was conducted. HRQoL was evaluated at baseline (wait listing) and after 6 and 12 months using the patient self-reported Kidney Disease and Quality of Life Short form version 1.3. Intra-individual scores at different times were evaluated. Generic HRQoL was compared with scores from an age-matched Norwegian population. RESULTS: From January 2013 to November 2016, 261 patients ≥65 years accepted for deceased donor kidney transplantation were included. Mean age at inclusion was 71.1 years, 67% male and 69% were on dialysis. HRQoL sum scores significantly decreased during the first year on the waiting list. Physical, mental and kidney disease component summary score reduced from 39.6 to 38.1 (P = 0.045), 48.8 to 44.7 (P < 0.001) and 72.1 to 70.2 (P = 0.03), respectively. When evaluating each domain separately, only the decrease in social function was clinically significant. Age and being on dialysis were the most important predictors for low HRQoL. Compared to the age-matched general population, males had significant lower HRQoL scores. Females were comparable to the general female population at baseline except in general health and vitality. CONCLUSIONS: HRQoL in older patients waiting for kidney transplantation decreases during the first year on the waiting list, but only the change in social function is clinically significant.
AIM: There is limited available knowledge regarding health-related quality of life (HRQoL) in older patients with chronic kidney disease. We aimed to describe HRQoL in renal transplant candidates 65 years or older at transplant acceptance, and during the first year on the waiting list. METHODS: A nationwide prospective observational study in Norway was conducted. HRQoL was evaluated at baseline (wait listing) and after 6 and 12 months using the patient self-reported Kidney Disease and Quality of Life Short form version 1.3. Intra-individual scores at different times were evaluated. Generic HRQoL was compared with scores from an age-matched Norwegian population. RESULTS: From January 2013 to November 2016, 261 patients ≥65 years accepted for deceased donor kidney transplantation were included. Mean age at inclusion was 71.1 years, 67% male and 69% were on dialysis. HRQoL sum scores significantly decreased during the first year on the waiting list. Physical, mental and kidney disease component summary score reduced from 39.6 to 38.1 (P = 0.045), 48.8 to 44.7 (P < 0.001) and 72.1 to 70.2 (P = 0.03), respectively. When evaluating each domain separately, only the decrease in social function was clinically significant. Age and being on dialysis were the most important predictors for low HRQoL. Compared to the age-matched general population, males had significant lower HRQoL scores. Females were comparable to the general female population at baseline except in general health and vitality. CONCLUSIONS: HRQoL in older patients waiting for kidney transplantation decreases during the first year on the waiting list, but only the change in social function is clinically significant.
Authors: Anna R Gagliardi; Cindy Y Y Yip; Jonathan Irish; Frances C Wright; Barry Rubin; Heather Ross; Robin Green; Susan Abbey; Mary Pat McAndrews; Donna E Stewart Journal: Health Expect Date: 2021-03-26 Impact factor: 3.318
Authors: Kjersti Lønning; Kristian Heldal; Tomm Bernklev; Cathrine Brunborg; Marit Helen Andersen; Nanna von der Lippe; Anna Varberg Reisæter; Pål-Dag Line; Anders Hartmann; Karsten Midtvedt Journal: Transplant Direct Date: 2018-03-01
Authors: Vasiliki Tsarpali; Karsten Midtvedt; Kjersti Lønning; Tomm Bernklev; Nanna von der Lippe; Anna Varberg Reisæter; Cathrine Brunborg; Kristian Heldal Journal: Kidney Med Date: 2021-07-22
Authors: Vasiliki Tsarpali; Karsten Midtvedt; Kjersti Lønning; Tomm Bernklev; Anders Åsberg; Haris Fawad; Nanna von der Lippe; Anna Varberg Reisæter; Kjetil Røysland; Kristian Heldal Journal: Transplant Direct Date: 2022-03-23
Authors: Amarpreet K Thind; Annabel Rule; Dawn Goodall; Shuli Levy; Sarah Brice; Frank J M F Dor; Nicola Evans; David Ospalla; Nicola Thomas; David Wellsted; Lina Johansson; Michelle Willicombe; Edwina A Brown Journal: BMC Nephrol Date: 2022-08-13 Impact factor: 2.585
Authors: Vasiliki Tsarpali; Karsten Midtvedt; Kjersti Lønning; Tomm Bernklev; Anders Åsberg; Nanna von der Lippe; Anna Varberg Reisæter; Kristian Heldal Journal: Transplant Direct Date: 2022-10-07
Authors: Sarah Elshahat; Paul Cockwell; Alexander P Maxwell; Matthew Griffin; Timothy O'Brien; Ciaran O'Neill Journal: PLoS One Date: 2020-03-24 Impact factor: 3.240